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a b s t r a c t 
Background: The distribution of intestinal parasites among patients with tuberculosis in Ethiopia is not 
well understood. 
Objective: This systematic review and meta-analysis was designed to determine the pooled national 
prevalence of intestinal parasites and its association with HIV among patients with tuberculosis in 
Ethiopia. 
Methods: Original articles were searched in PubMed, Google Scholar, EMBASE, World Health Organiza- 
tion’s HINARI portal, and supplemented by the hand searching of cross-references. Data were extracted 
using a standard data extraction checklist. Random-effects model was used to estimate the pooled preva- 
lence of intestinal parasites and odds ratio of the association. The I 2 statistic was utilized to quantify 
statistical heterogeneity across studies. Funnel plot asymmetry and Egger regression tests were used to 
check for publication bias. The analysis was done by STATA version 14 for Windows. 
Results: Of 725 identified studies, 12 articles were eligible for inclusion in the final analysis. The pooled 
national prevalence of intestinal parasites among patients with tuberculosis in Ethiopia was 36.1% (95% CI, 
22.1–50.1; I 2 = 98.7%). Subgroup analysis based on study design indicated that the prevalence of intestinal 
parasite among case-control studies was 41.69% (95% CI, 28.6–54.8; I 2 = 95.1%). The odds of intestinal 
parasites among patients with tuberculosis–HIV coinfection was not significantly different com pared with 
patients with tuberculosis without HIV/AIDS (odds ratio = 0.99; 95% CI, 0.7—4.7; P = 0.96). 
Conclusions: In Ethiopia, at least 1 out of 3 patients with tuberculosis have an intestinal parasite. These 
findings suggest a need of more attention on increasing screening tuberculosis patients for intestinal 
parasites and deworming interventions. ( Curr Ther Res Clin Exp . 2020; 81:XXX–XXX) 
© 2020 The Author(s). Published by Elsevier Inc. 
This is an open access article under the CC BY-NC-ND license 














Parasitic and tuberculosis (TB) infections are among the most
revalent infections in humans in developing countries. 1 The over-∗ Address correspondence to: Getenet Dessie, Department of Nursing, School of 
ealth Science, College of Medicine and Health Science, Bahr Dar University, PO 
ox 79, Bahr Dar, Ethiopia 
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onsistent figures all over the world. 2–6 More than half of people
ith latent or active TB infections have intestinal parasite infection
IPI), which is common in high TB burden nations. 7 In Africa, one-
hird of TB patients have an IPI 8 that contributes to the high rate
f therapeutic failure of pulmonary TB. 9 
It is evident that pulmonary TB and parasitic diseases were
hown to be risk factors for each other and represented with high
agnitude of comorbidity in developing countries. 8 , 10 Coinfectionunder the CC BY-NC-ND license 
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ay significantly inhibit the host’s immune system, increase an-
ibacterial therapy intolerance, and be detrimental to the prognosis
f the disease. In addition, infection with parasitic diseases can al-
er the protective immune response to mycobacterium TB. This in-
icates that concomitant helminthic infections weaken immune re-
istance to mycobacterial infections. 11 , 12 Furthermore, the presence
f intestinal parasites affects the effectiveness of vaccine against
B and increases the chance of developing active TB diseases after
accination. 13 
In addition, parasitic infection presented with more severe radi-
logical pulmonary disease in the number of involved lung zones
t the end of TB treatment. In particular, simultaneous intestinal
elminth infection in patients with newly diagnosed TB alters a
atient’s immunity profile that could favor persistent mycobac-
erium TB infection and a more protracted clinical course of the
isease. 14 , 15 
In developing countries, parasitic worm infections among TB
atients are common and increases the chance for TB complica-
ions. 16 , 17 Parasitic infection increases the chance of TB lung dam-
ge and induces the progression of a latent TB infection to active
B disease. 16 , 17 The presence of high TB progression, delay in clin-
cal response and sustained infectiousness leads to high transmis-
ion rate of TB to healthy individuals. 18–20 
There are factors that increase the risk of having parasites in-
ection among TB patients. Personal hygiene, residence, eosinophils
ount, and habit of washing vegetables/fruits are some of the fac-
ors listed in previous studies. 10 , 21 , 22 On 1 hand, the presence of
mmunocompromised diseases, such as HIV/AIDS, are associated
ith TB. On the other hand, HIV/AIDS is supposed to be a risk fac-
or for IPIs. 23 Currently, there is high prevalence of TB/HIV comor-
s  
Downloaded for Anonymous User (n/a) at University of Groning
For personal use only. No other uses without permissionidity that was estimated to be from 22% to 25.6% in Ethiopia. 24–26 
arasitic infections represent a major public health problem in im-
unocompromised individuals. 23 HIV infection accounts for the
ighest prevalence of IPIs among TB patients in comparison with
B patients without immunodeficiency, 27 whereas another finding
ndicates significantly lower prevalence of IPIs among HIV-positive
B patients. 2 
In sum, high prevalence of TB and IPIs comorbidity can be ex-
lained by low level of socioeconomic and immunity status. 28 Lit-
rature about the prevalence of and risk factors for intestinal par-
sites among these vulnerable populations exhorts policy makers
nd program planners to pay due attention and take appropriate
easures. There is limited understanding of the extent of para-
itosis comorbidities with TB in Ethiopia. The few available evi-
ences are inconclusive and inconsistent. Hence, pointing out the
verall level of comorbidity might alarm policy makers and min-
stries of health into developing interventional guidelines or bi-
irectional frameworks for effective treatment of TB and parasite
nfection comorbidity as well as successful implementation of a
ational TB control and prevention strategy. This systematic review
nd meta-analysis aimed to determine the pooled national preva-
ence of IPI and its association with HIV among patients with TB in
thiopia. 
ethods 
earch approach and appraisal of studies 
Articles were accessed through web-based electronic database
earches, desk reviews of the grey literature, and cross-referencesen from ClinicalKey.com by Elsevier on October 09, 2020.
. Copyright ©2020. Elsevier Inc. All rights reserved.
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Table 1 
Characteristics of included studies for the present systematic review and meta-analysis, 2004–2018, in Ethiopia. 
Reference Publication 
year 
Region Diagnostic method 
for TB 
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> 12 100 Not stated 44 6.5 
Afework, 
et al 42 


















et al 46 




Not stated Case 
control 




et al 37 











100 Not stated 29 6.5 
Alemayehu 
et al 39 
2014 Amhara Sputum smear, 
Xpert MTB/RIF 





2–80 100 Not stated 33.3 7 
Abate 
et al 38 
2015 Amhara Sputum smear, 
radiographic 
examination 
consistent with TB, 









15–60 100 Not stated 40 7 
Hailu 
et al 41 




Not stated Case 
control 



































et al 44 






≥5 100 University 
of Gondar 
2 6.5 
AFB = acid-fast bacilli; MTB/RIF = mycobacterium tuberculosis/rifampin; SAREC = Sustainable Agriculture Research and Extension Center; SIDA = Swedish International Devel- 
opment Cooperation Agency; SNNPR = Southern Nations, Nationalities, and Peoples’ Region; TB = tuberculosis. 
Table 2 
Meta regression results on selected variables. 
Variable Coefficient P value 
Publication year –3.9 0.06 
Sample size 0.2 0.03 
Adis Ababa 20 –19 0.51 
Amhara 37–42 , 44 4.1 0.84 
Oromia 45 , 46 8.3 0.72 

















s  f identified studies. The electronic databases searched were
ubMed, Google Scholar, EMBASE, and the World Health Organi-
ation database portal for low- and middle-income countries thatDownloaded for Anonymous User (n/a) at University of Groningen 
For personal use only. No other uses without permission. Concludes the Web of Science, SCOPUS, African Index Medicus, Cu-
ulative Index to Nursing and Allied Health Literature, the World
ealth Organization Institutional Repository for Information Shar- 
ng, and African Journals Online databases. In addition, related ar-
icles were obtained through review of the grey literature available
n institutional repository 29 and from reviewing cross-references 
f identified articles. 
Searching was done using the following key terms: intesti-
al diseases , parasitic , intestinal , diseases , parasitic , parasitic in-
estinal diseases , intestinal , parasites , intestinal parasites , intestinal
elminthes , intestinal protozoa , soil-transmitted helminthes , tubercu-
osis , HIV , patients , and Ethiopia . These key terms were combined
sed AND and OR Boolean operators. To allow a comprehensive
earch strategy, these key terms were predefined that includedfrom ClinicalKey.com by Elsevier on October 09, 2020.
pyright ©2020. Elsevier Inc. All rights reserved.
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i  ll fields within records. Medical subject headings terms was also
sed to help expand the search in advanced PubMed search. The
tudy period for searching of article was conducted from Novem-
er 10, 2018, to February 1, 2019. Endnote citation manager soft-
are version X7 for Windows was utilized to collect and organize
earch outcomes and for removal duplicate articles. 
nclusion and exclusion criteria 
All articles for the study were included if they met the fol-
owing inclusion criteria: written in English-language, full-text arti-
les on observational studies (case-control or cross-sectional), con-
ucted in Ethiopia from 2004 to 2018, published in peer-reviewed
ournals or available at university repository, and used valid and
eliable diagnostic criteria to diagnose intestinal parasite. Studies
hat did not report specific outcomes for intestinal parasites quan-
itatively were excluded from the final analysis. 
ata abstraction and quality assessment 
After preliminary assessment, 2 reviewers downloaded ab-
tracts to assess for inclusion. The abstracts were assessed for
greement with the inclusion criteria. When it was unclear
hether or not an abstract was relevant, it was included for re-
rieval. At this stage, articles deemed irrelevant or out of the
cope of the study were excluded and the full-text of the re-
aining articles downloaded for a detailed review. Two review-
rs then assessed the quality of potentially eligible articles usingDownloaded for Anonymous User (n/a) at University of Groning
For personal use only. No other uses without permissionewcastle-Ottawa Scale criteria 30 that was validated previously. 31 
here are 3 main categories for Newcastle-Ottawa Scale criteria:
election, exposure, and comparability. A study can be awarded a
aximum of 1 star for each numbered item within the selection
nd exposure categories. A maximum of 2 stars can be given for
omparability categories. Then the number of stars that was given
or each numbered item was computed to determine the qual-
ty score of each study. Discrepancies in quality assessment scores
ere resolved with a third reviewer whenever appropriate. The av-
rage of 2 independent reviewer’s score was used to determine the
uality of each article. The current systematic review and meta-
nalysis was conducted in accordance with the Preferred Reporting
tems for Systematic Reviews and Meta-Analyses Protocol guide-
ines. 32 
ata analysis 
Using an Excel (Microsoft, Redmond, Washington) spreadsheet
emplate based on Joanna Briggs Institute format, author name,
ublication year, region, dominant parasites, the age range of pa-
ients, and funding source were extracted from each study. 33 These
ata were then imported to Stata version 14 software for Win-
ows (Stata Corp, College Station, Texas) to compute the pooled
revalence of intestinal parasites and to examine the associa-
ion with HIV. The statistical heterogeneity of study outcomes
as assessed using the I 2 statistic. 34 Methodological heterogene-
ty was evaluated by comparing study design. Additionally, clin-
cal heterogeneity that can arise from differences in participanten from ClinicalKey.com by Elsevier on October 09, 2020.
. Copyright ©2020. Elsevier Inc. All rights reserved.
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a  haracteristics (eg, sex, age, baseline disease severity, ethnicity, and
omorbidities) and types or timing of outcome measurements was
ssessed with face-to-face discussion by the authors. First, we set
nd agreed on definitions of variations in sex, age, baseline dis-
ase severity, ethnicity, comorbidities, and types or timing of out-
ome measurements. Next, we discussed and reached consensus
bout how much this heterogeneity influenced our pooled analysis.
 random-effects model was used to estimate the pooled preva-
ence of IPIs at a 95% CI. Because theoretically we expected that
he study settings and socioeconomic contexts might differ radi-
ally across these studies, subgroup analysis was based on study
esign and group of parasites. We used visual examination of fun-
el plot asymmetry and Egger regression tests to check for pub-
ication bias. 35 Meta-regression analysis was employed to identify
he source of heterogeneity using publication years, sample size,
nd region as covariates. Sensitivity analysis was also performed
o examine influence of each study on the overall effect size. We
ppraised the risk of bias using the 10-item rating scale developed
y Hoy et al 36 for prevalence studies. The tool assesses studies on
0 domains, including sampling, data collection, reliability and va-
idity of study tools, case definition, and prevalence periods. Each
tudy was assigned a score of 1 (yes answers to domain ques-
ions) or 0 (no answers to domain questions) for each domain,
nd these scores were summed to provide an overall study qual-
ty score. Scores of 8 to 10 were considered as having a low risk of o  
Downloaded for Anonymous User (n/a) at University of Groningen 
For personal use only. No other uses without permission. Coias, 6 to 7 a moderate risk of bias, and 0 to 5 a high risk of bias.
or the final risk of bias classification, disagreements between the
eviewers were resolved via consensus (see Supplemental Figure 1
n the online version). 
esults 
dentification and description of studies 
Of 725 identified studies, 260 duplicate articles were excluded
fter reviewing the titles and abstracts. Next, 452 articles were ex-
luded with a reason of irrelevance. Finally, the full-text of the re-
aining 13 articles were downloaded and assessed for quality and
or the presence of all required information. One article was ex-
luded because the outcome was not clearly stated. 17 The remain-
ng 12 studies were included in the final meta-analysis ( Fig. 1 ). 
haracteristics of included studies 
Twelve studies with a total sample of 1927 TB patients were
ncluded. Most of the study participants belonged to the age
ange 2 to 100 years. Eight studies were conducted in Amhara re-
ion, 37–44 2 in Oromia region, 45 , 46 and 2 studies in Addis Ababa
nd SNNPR. 21 , 22 All studies used direct microscope examination
f stool to identify intestinal parasites. Half of the studies werefrom ClinicalKey.com by Elsevier on October 09, 2020.
pyright ©2020. Elsevier Inc. All rights reserved.
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T  ase-control study. The quality score ranges from 6 to 7 with mean
SD) score of 6.8 (0.25) ( Table 1 ). 
revalence of intestinal parasite 
Both the lowest (2%) 44 and highest (40.5%) 42 prevalence of in-
estinal parasites were reported in Amhara region. The pooled
ational prevalence of intestinal parasites among TB patients in
thiopia was 36.11% (95% CI, 22.08–50.13; I 2 = 98.7%; P = 0.01)
 Fig. 2 ). Visual examination of the funnel plot revealed deviation
see Supplemental Figure 2 in the online version). However, both
egg ( P = 0.27) and Egger tests ( P = 0.57) of the intercept indicated
he absence of significant publication bias. 
ubgroup and sensitivity analysis 
Based on the subgroup analysis, the pooled prevalence of in-
estinal parasites among case-control studies was 41.69% (95% CI,
8.57–54.81; P = 0.01; I 2 = 95.1%) and 30.45% (95% CI, 11.66–49.24;
 = 0.01; I 2 = 98.7%) in cross-sectional studies ( Fig. 3 ). 
Additionally, subgroup analysis based on types of intestinal
arasites showed that the highest percentage was reported for
elminths species with a prevalence of 43.3% (95% CI, 30.4%–56.3%;
 
2 = 93.7%) ( Fig. 4 ). The sensitivity analysis showed that none of the
tudies significantly influenced the overall pooled estimate of IPI. Downloaded for Anonymous User (n/a) at University of Groning
For personal use only. No other uses without permissioneta-regression analysis 
The univariate meta-regression analysis showed that a 1-person
ncreases of sample size brought a variation on prevalence of each
tudy by 0.2 ( P = 0.03) ( Table 2 ). 
IV status and IPI 
Six studies 22 , 37 , 38 , 40 , 42 , 43 reported the association between HIV
tatus and IPI. The odds of intestinal parasites among TB patients
ith HIV/AIDS was not significantly different compared with TB
atients without HIV/AIDS (odds ratio = 0.99; 95% CI, 0.71–4.71;
 
2 = 41.5%; P = 0.13) ( Fig. 5 ). Although the funnel plot showed slight
eviation (see Supplemental Figure 3 in the online version), Begg
 P = 0.57) and Egger ( P = 0.91) tests showed the absence of signifi-
ant publication bias. 
iscussion 
TB and intestinal parasites overlap geographically, and can rep-
esented with high prevalence in the area where there is poor so-
ioeconomic status. 47 Additionally, it is evident that due to com-
licated immune status of TB patients with immunodeficiency dis-
rders, this group of patients are at higher risk of developing IPI. 27 
o our knowledge, this is the first meta-analysis in Ethiopia to pro-en from ClinicalKey.com by Elsevier on October 09, 2020.
. Copyright ©2020. Elsevier Inc. All rights reserved.
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ide the pooled national prevalence of intestinal parasites and its
ssociation with HIV among TB patients. The national prevalence
f intestinal parasites among patients with TB was 36.11%. This
nding is consistent with a report in Tanzania with prevalence of
1.8%. 8 
Our finding was high compared to a report in Egypt (16%) 9 
nd China (21.7%). 48 The Egyptian study 9 was only assessed the
urden of a single parasite, which was not a dominant parasite
n our finding. In our study, Ascaris lumbricoides was the dom-
nant parasite. Thus, high prevalence of A lumbricoides in our
tudy might increase the overall IPIs prevalence and can be ac-
ounted for this variation. Ascariasis is the most common para-
ite that found in warm tropical and subtropical regions of the
orld, including Ethiopia. 49 Due to the presence of high utiliza-
ion of unsafe water, unhygienic living conditions, and unsanitary
aste management, 50 Ethiopia stands out for having the highest
urden of ascariasis cases following Nigeria and the Democratic
epublic of Congo. Almost one-third of Ethiopians have been in-
ected with ascariasis. 51 In A lumbricoides endemic areas, it is ex-
ected to have high rate of A lumbricoides and TB/HIV coinfec-
ion. 52 Socioeconomic difference between Ethiopia and China ex-
lain this discrepancy. Ethiopia is low-income country whose peo-
les live under poverty whereby risk factors, such as poor san-
tation, low health awareness, low urbanization, low health care
ervice, and high burden of parasitosis are evident compared with
hina. 53 In China, the Chinese Center for Disease Control and Pre-
ention provide specialized hospital care for patients with IPIs.
he presence of this care unit attributed to the nationwide scale-
p of TB management and a national TB control program. Pa-
ients in a specialized care unit have better follow-up, receive ap-Downloaded for Anonymous User (n/a) at University of Groningen 
For personal use only. No other uses without permission. Coropriate examinations, treatment regimens, and rigorous super- 
ision when compared with patients who take treatment at the
ospital level. 54 Consequently, the burden of IPIs in China might
ecrease. 55 
On the other hand, our finding was lower than the study report
n Brazil (65%). 7 This difference can be explained by the variation
n the study area. Our study estimated the prevalence in studies
onducted without consideration of socioeconomic class. However, 
he Brazilian study 7 was conducted among a low-income commu-
ity, in particular in the area where there is inadequate sanitary
tructure, latrines being shared with other rooms, well water as
he main source of drinking water, and near to half of families had
ow income. 
Our subgroup analysis result showed that estimate from case-
ontrol studies was higher than cross-sectional studies. This differ-
nce might happen related to the nature of sample selection. The
nique advantage of cross-sectional surveys is that it is possible to
etermine the prevalence of an outcome because the study sam-
les are selected randomly. 56 Conversely, in case-control studies ,
ases and/or controls are selected on criteria related to the expo-
ure of interest that can influence the overall prevalence. 57 Based
n the category of parasite subgroup analysis, the highest per-
entage was reported for helminths group with a prevalence of
3.3%. This finding was consistent with previous studies conducted
mong people with TB. 2 , 10 However, our finding was totally dif-
erent from large surveys report on non-TB people in Ethiopia, 58 
hana, 59 and Brazil 60 with higher proportion of protozoal infec-
ion reported than helminths. This evidence suggests the presence
f strong immunological and geographical connection between from ClinicalKey.com by Elsevier on October 09, 2020.
pyright ©2020. Elsevier Inc. All rights reserved.





















































































































elminths and TB that contributes to high burden of helminthiases
mong TB patients. 61–63 
The present meta-analysis showed that the odds of intestinal
arasites among TB patients was not significantly different in pa-
ients with or without HIV. Similarly, previous studies concluded
hat the presence of HIV could not contribute to high parasitosis
mong TB patients. 8 , 10 This might be due to the presence of better
ollow-up for patients with HIV. Currently, there is better aware-
ess of professionals in adopting prevention and treatment mea-
ures against opportunistic infection, such as intestinal parasites in
IV patients. In addition, the current Ethiopian antiretroviral ther-
py guideline recommend anthelminthic for antiretroviral therapy
atients for deworming purpose. During the past few years, the
resence of appropriate follow-up and treatment for IPIs at an-
iretroviral therapy clinics dramatically decreased the prevalence
mong HIV patients. 64 Moreover, patients might regain their im-
unity after initiation of antiretroviral therapy that can minimize
PI. 65 
The presence high helminths infection among patients with TB
n our finding implies that these patients are risk for sustained
nfectiousness that can lead to high transmission rate of TB to
ealthy individual. This issue directly interfere with the national
B control and prevention strategy. 18 Antigens from helminths and
ycobacteria have immunomodulatory activities that can affect
mmune responses for microbes. There is immunological evidence
emonstrating that helminths clearly alter the magnitude of the
ycobacteria-specific cytokine responses and the control of the
ycobacteria growth. This delays the clinical response of TB pa-
ients. 19 , 20 
Ethiopia is a country that has a high burden of multidrug-
esistant TB. 66 , 67 Timely management of risk factors like intestinal
arasitosis can improve the effectiveness of anti-TB treatment and
educe the magnitude of multidrug-resistant TB. It is known that
he effectiveness of anti-TB treatment is greatly influenced by du-
ation and patient adherence with anti-TB drugs. 68 Patients with
arasitosis comorbidities with TB presented with difficulty of ad-
erence with anti-TB treatment and low effectiveness of overall
B therapy. Consequently, it increases the burden of health insti-
ution workload, the occurrence of new TB infection, and the na-
ional burden of multidrug-resistant TB. 11 
In most developing countries where TB infection is prevalent,
arasitic infections are also predominant medical problems. 11 Re-
ucing the burden of these parasites is important to reduce the
ortality and morbidity associated with TB infection. Parasitic in-
ections have profoundly debilitating effects, particularly on the
mmune system of the host, potently compromising the host ca-
acity to cope with TB infection and to mount efficacious im-
une responses. In addition, without the eradication of helminthic
arasites, TB treatment would fail to confer protection for TB
nfection in TB endemic areas. This implies that eradication of
elminthic infections or modulation of the immune change that
hey cause should be instituted before plans to reach TB zero
revalence in the country. For example, de-worming for eradica-
ion of helminthic infections throughout the country in the context
f TB epidemics should be seriously considered. 14 , 69 
tudy Strengths and Limitations 
The present meta-analysis is the first in Ethiopia that can give
ationally pooled evidence about the overall national burden of
PIs among patients with TB. 
This meta-analysis has also limitations. First, most of the stud-
es reviewed were published in small regional journals, making it
ifficult to gauge the extent of peer review and quality of studies.
owever, all included studies passed the quality screening criteria.
econd, due to the absence of data, unadjusted odds ratios wereDownloaded for Anonymous User (n/a) at University of Groning
For personal use only. No other uses without permissionsed to estimate the effect size of HIV, which prevented us from
xcluding the confounding effect of other factors. The findings of
his meta-analysis would be best interpreted while keeping these
nalytical limitations and the limitations of the original studies in
ind. 
onclusions 
In Ethiopia, at least 1 out of 3 patients with TB have intesti-
al parasites. These findings suggest a need for more attention on
ncreasing screening of TB patients for intestinal parasites and de-
orming to reduce its influence on patients’ overall health status. 
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